Kidist Zewdie1, Catherine Kiptinness2, Kenneth Ngure3, Nicholas Kipkurui2, Njeri Wairimu2, Faith Ambiyo2, Nelly R Mugo2,4, Jared M Baeten1,4,5,6, Kenneth K Mugwanya1,4. 1. Department of Epidemiology, University of Washington, Seattle, WA. 2. Kenya Medical Research Institute, Nairobi, Kenya. 3. Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya. 4. Departments of Global Health; and. 5. Medicine, University of Washington, Seattle, WA; and. 6. Gilead Sciences, Foster City, CA.
Abstract
BACKGROUND: Partners of persons living with HIV (PLHIV) are at a high risk of HIV acquisition, particularly if PLHIV are newly diagnosed or not virally suppressed. A focused partner HIV testing strategy could stimulate efficient identification of persons for pre-exposure prophylaxis (PrEP) or antiretroviral therapy (ART) programs. METHODS: We sequentially implemented 2 partner testing strategies at 2 Kenyan HIV clinics: (1) an invitation for clinic-based testing and (2) HIV self-testing (HIVST) kits distribution to index PLHIV. For each testing strategy, we enrolled approximately 150 consecutive index PLHIV with partners of unknown HIV status, not on ART, <6 months on ART, or who had detectable viral load. We compared partner engagement, testing uptake, and linkage for ART or PrEP between the 2 testing strategies. RESULTS: Of 313 index PLHIV enrolled (160 in invitation, 153 in HIVST), the median age was 32 years (interquartile range 26-40) and 76% were women. Overall, 73% of participants (229) discussed HIV testing with their partners: 76% (121) in the invitation strategy vs 71% (108) in the HIVST strategy [adjusted odds ratio (adjOR): 0.54, 95% confidence interval (CI): 0.31 to 0.97]. Overall, 52% (79) partners in the HIVST strategy tested vs 38% (60) in the invitation strategy (adjOR: 1.78, 95% CI: 1.13 to 2.78). Among partners engaged, 73% in the HIVST strategy vs 50% in the invitation tested (adjOR: 2.68, 95% CI: 1.46 to 4.96); 25% (35/139) tested positive for HIV. Eighty-nine percentage (31/35) who tested positive initiated treatment, but only 21% (20/93) who tested negative initiated PrEP. CONCLUSIONS: HIVST kit distribution to PLHIV with partners of unknown HIV status effectively increased partner testing. Only one-fifth of partners who tested negative initiated PrEP-thus innovations to link to prevention services are urgently needed.
BACKGROUND: Partners of persons living with HIV (PLHIV) are at a high risk of HIV acquisition, particularly if PLHIV are newly diagnosed or not virally suppressed. A focused partner HIV testing strategy could stimulate efficient identification of persons for pre-exposure prophylaxis (PrEP) or antiretroviral therapy (ART) programs. METHODS: We sequentially implemented 2 partner testing strategies at 2 Kenyan HIV clinics: (1) an invitation for clinic-based testing and (2) HIV self-testing (HIVST) kits distribution to index PLHIV. For each testing strategy, we enrolled approximately 150 consecutive index PLHIV with partners of unknown HIV status, not on ART, <6 months on ART, or who had detectable viral load. We compared partner engagement, testing uptake, and linkage for ART or PrEP between the 2 testing strategies. RESULTS: Of 313 index PLHIV enrolled (160 in invitation, 153 in HIVST), the median age was 32 years (interquartile range 26-40) and 76% were women. Overall, 73% of participants (229) discussed HIV testing with their partners: 76% (121) in the invitation strategy vs 71% (108) in the HIVST strategy [adjusted odds ratio (adjOR): 0.54, 95% confidence interval (CI): 0.31 to 0.97]. Overall, 52% (79) partners in the HIVST strategy tested vs 38% (60) in the invitation strategy (adjOR: 1.78, 95% CI: 1.13 to 2.78). Among partners engaged, 73% in the HIVST strategy vs 50% in the invitation tested (adjOR: 2.68, 95% CI: 1.46 to 4.96); 25% (35/139) tested positive for HIV. Eighty-nine percentage (31/35) who tested positive initiated treatment, but only 21% (20/93) who tested negative initiated PrEP. CONCLUSIONS: HIVST kit distribution to PLHIV with partners of unknown HIV status effectively increased partner testing. Only one-fifth of partners who tested negative initiated PrEP-thus innovations to link to prevention services are urgently needed.
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: Reinhard Kaiser; Rebecca Bunnell; Allen Hightower; Andrea A Kim; Peter Cherutich; Mary Mwangi; Tom Oluoch; Sufia Dadabhai; Patrick Mureithi; Nelly Mugo; Jonathan Mermin Journal: PLoS One Date: 2011-03-15 Impact factor: 3.240
Authors: Augustine Talumba Choko; Nicola Desmond; Emily L Webb; Kondwani Chavula; Sue Napierala-Mavedzenge; Charlotte A Gaydos; Simon D Makombe; Treza Chunda; S Bertel Squire; Neil French; Victor Mwapasa; Elizabeth L Corbett Journal: PLoS Med Date: 2011-10-04 Impact factor: 11.069
Authors: Jared M Baeten; Renee Heffron; Lara Kidoguchi; Nelly R Mugo; Elly Katabira; Elizabeth A Bukusi; Stephen Asiimwe; Jessica E Haberer; Jennifer Morton; Kenneth Ngure; Nulu Bulya; Josephine Odoyo; Edna Tindimwebwa; Craig Hendrix; Mark A Marzinke; Norma C Ware; Monique A Wyatt; Susan Morrison; Harald Haugen; Andrew Mujugira; Deborah Donnell; Connie Celum Journal: PLoS Med Date: 2016-08-23 Impact factor: 11.069
Authors: Kenneth Ngure; Renee Heffron; Nelly Mugo; Kerry A Thomson; Elizabeth Irungu; Njambi Njuguna; Lawrence Mwaniki; Connie Celum; Jared M Baeten Journal: J Int AIDS Soc Date: 2017-02-10 Impact factor: 5.396
Authors: Jairam R Lingappa; Erin Kahle; Nelly Mugo; Andrew Mujugira; Amalia Magaret; Jared Baeten; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; James Kiarie; Carey Farquhar; Grace John Stewart; Joseph Makhema; M Essex; Edwin Were; Kenneth Fife; Guy Debruyn; Glenda Gray; James McIntyre; Rachel Manongi; Saidi Kapiga; David Coetzee; Susan Allen; Mubiana Inambao; Kayitesi Kayitenkore; Etienne Karita; William Kanweka; Sinead Delany; Helen Rees; Bellington Vwalika; Robert W Coombs; Rhoda Morrow; William Whittington; Lawrence Corey; Anna Wald; Connie Celum Journal: PLoS One Date: 2009-04-30 Impact factor: 3.240